Page last updated: 2024-10-19

phenylacetic acid and Melanoma

phenylacetic acid has been researched along with Melanoma in 3 studies

phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.

Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)

Research Excerpts

ExcerptRelevanceReference
"By contrast, treatment of melanoma cells that were in a more advanced stage of maturation resulted in profound alterations in cell growth, morphology, and pigmentation consistent with terminal differentiation."1.29Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate. ( Hudgins, WR; Liu, L; Samid, D; Shack, S; Stetler-Stevenson, WG, 1994)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, L2
Hudgins, WR2
Miller, AC1
Chen, LC1
Samid, D2
Shack, S1
Stetler-Stevenson, WG1
Gervelas, C1
Avramoglou, T1
Crépin, M1
Jozefonvicz, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Progressive or Recurrent CNS Malignancy[NCT00006450]Phase 2120 participants Interventional2000-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

3 other studies available for phenylacetic acid and Melanoma

ArticleYear
Transcriptional upregulation of TGF-alpha by phenylacetate and phenylbutyrate is associated with differentiation of human melanoma cells.
    Cytokine, 1995, Volume: 7, Issue:5

    Topics: Antineoplastic Agents; Cell Differentiation; Culture Media; Gene Expression Regulation, Neoplastic;

1995
Differentiation of cultured human melanoma cells induced by the aromatic fatty acids phenylacetate and phenylbutyrate.
    The Journal of investigative dermatology, 1994, Volume: 103, Issue:3

    Topics: Antineoplastic Agents; Carcinogenicity Tests; Cell Differentiation; Cell Division; Drug Synergism; F

1994
Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA-dextran conjugate.
    Anti-cancer drugs, 2002, Volume: 13, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cell Survival; Dextrans; Dru

2002